Why the study?
Existing risk prediction tools for syncope in the emergency department have suboptimal performance, and the application of machine learning models remains underexplored.
Does a hybrid machine learning model improve the prediction of 30-day clinically significant outcomes in patients presenting to the ED for syncope compared to an XGBoost model alone?
Does a hybrid machine learning model improve the prediction of 30-day clinically significant outcomes in patients presenting to the ED for syncope compared to an XGBoost model alone?
A hybrid machine learning model integrating XGBoost with knowledge-based rules significantly improved the prediction of 30-day adverse events in ED syncope patients using only routinely collected clinical data.
Answers are grounded in this paper and cite their sources.
Hybrid ML may improve 30-day risk stratification for ED syncope with routine data; supports prospective validation before clinical use.
Syncope is a challenging problem in the emergency department (ED) as the available risk prediction tools have suboptimal predictive performances. Predictive models based on machine learning (ML) are promising tools whose application in the context of syncope remains underexplored. The aim of the present study was to develop and compare the performance of ML-based models in predicting the risk of clinically significant outcomes in patients presenting to the ED for syncope. We enrolled 266 consecutive patients (age 73, IQR 58–83; 52% males) admitted for syncope at three tertiary centers. We collected demographic and clinical information as well as the occurrence of clinically significant outcomes at a 30-day telephone follow-up. We implemented an XGBoost model based on the best-performing candidate predictors. Subsequently, we integrated the XGboost predictors with knowledge-based rules. The obtained hybrid model outperformed the XGboost model (AUC = 0.81 vs. 0.73, p < 0.001) with acceptable calibration. In conclusion, we developed an ML-based model characterized by a commendable capability to predict adverse events within 30 days post-syncope evaluation in the ED. This model relies solely on clinical data routinely collected during a patient’s initial syncope evaluation, thus obviating the need for laboratory tests or syncope experienced clinical judgment.
No takes yet. Share an insight, caveat, or question.
Dipaola et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: